Burning Rock Biotech Limited carried $243K in long-term debt against $68.4M in cash and equivalents at the end of fiscal year 2025. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Burning Rock Biotech Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BNR Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BNR Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Burning Rock Biotech Limited financials
Frequently Asked Questions
What was Burning Rock Biotech Limited's long-term debt in fiscal year 2025?
Burning Rock Biotech Limited carried $243K in long-term debt against $68.4M in cash and equivalents at the end of fiscal year 2025.
How has Burning Rock Biotech Limited's long-term debt changed over the years?
Across the 6 fiscal years this page covers, Burning Rock Biotech Limited (BNR) long-term debt went from $0 in fiscal year 2020 to $243K in fiscal year 2025.
What was Burning Rock Biotech Limited's long-term debt in the most recent quarter?
Burning Rock Biotech Limited (BNR) reported $243K in long-term debt in Q4 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Burning Rock Biotech Limited (BNR) reported on that line in every period on record.